|
| | Issue Date | Title | Author(s) |
| 21 | 2019 | Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors | Oudah, Khulood H; Najm, Mazin A A; Samir, Nermin ; Serya, Rabah ; Khaled A M Abouzid |
| 22 | 2019 | Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity | Elsayed, Nevine M Y; Serya, Rabah ; Tolba, Mai ; Ahmed, Marawan; Barakat, Khaled; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 23 | 2019 | Selective Small Molecule Myeloid Cell Leukemia-1 (MCL-1) Inhibitors: Novel Agents in Cancer Therapy | Ibrahim, Hoda Sobhy; Lasheen, Deena S; Serya, Rabah ; Abu-ELElla, Dalal Abd-ELRahman |
| 24 | Dec-2019 | Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activities | Jaballah, Maiy Y; Serya, Rabah ; Saad, Nasser; Khojah, Sohair M; Ahmed, Marawan; Barakat, Khaled; Khaled A M Abouzid |
| 25 | 2020 | Synthesis, Biological Evaluation and In Silico Investigation of Novel Functionalized Imidazole-Based KDM6 Inhibitors | Serya, Rabah ; El-Araby, Amr; Qassem, Omar; El-Sawy, Ezzat; El-Razaz, Eman; Abouzid, Khaled |
| 26 | 1-Aug-2020 | Penicillin binding protein 2a: An overview and a medicinal chemistry perspective | Shalaby, Menna-Allah W; Dokla, Eman ; Serya, Rabah ; Khaled A M Abouzid |
| 27 | Feb-2022 | Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity | Farahat, Aya A; Samir, Eman M; Zaki, Mayssoune Y; Abdel-Aziz, Hatem A; Serya, Rabah |
| 28 | Dec-2022 | Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells | Abdelhafiz, Abeer H A; Lasheen, Deena S. ; Wang, Nessa; Sobeh, Mansour; Wink, Michael; Abouzid, Khaled ; Serya, Rabah |
| 29 | 2023 | Hit Identification Against Candida Albicans: Design, Synthesis, Molecular Docking and Biological Evaluation of Hybrid Styryl-Quinoxaline Based Analogues. | Jaballah, Maiy Y; Alaraby, Mohamed; Serya, Rabah ; Abouzid, Khaled |
| 30 | 2023 | AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase | Nada Alaa El-Deen; Mai Jaballah; Abouzid, Khaled ; Dokla, Eman ; Serya, Rabah |
| 31 | 2023 | Identification of Novel 4-Oxo-4H-chromen-Hydroxamic Acid Derivative Targeting Selected HDAC Isoforms | Ashraf, Rosaline; Serya, Rabah ; Abouzid, Khaled AM; Adel, Mai |
| 32 | 2024 | Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents | Nabih, Nadine W; Jaballah, Maiy Y; Serya, Rabah ; Abouzid, Khaled AM |
| 33 | Jun-2024 | Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Abouzid, Khaled A M; Serya, Rabah |
| 34 | 2025 | Next-Generation Diarylurea Antibacterials: From Structural Design and Optimization to Microbial Target Specific Strategies | Kassab, Rafif Rashad; Serya, Rabah Ahmed; Serya, Rabah ; Nermin Samir ; Abouzid, Khaled |
| 35 | May-2025 | Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML | El-Deen, Nada Alaa; DeFilippis, RosaAnna; Milik, Sandra N; Patel, Suhana; Ismail, Muhammad I; Khaled, Omar; Ahmed, Tarek Erfan; Abdelfattah, Ayatullah Gamal; Ali, Eslam M H; Gaballah, Maiy Y; McPhillie, Martin J; Abouzid, Khaled A M; Henary, Maged; Minucci, Saverio; Shah, Neil P; Abdel-Aziz, Amal Kamal ; Serya, Rabah ; Dokla, Eman |
| 36 | 1-Jul-2025 | Targeting DNA repair mechanisms: Spirobenzoxazinone and salicylamide derivatives as novel candidates for PARP-1 inhibition in cancer therapy | Kadry, Alaa Ahmed; Adel, Mai; Abubshait, Samar A; Yahya, Galal; Sharaky, Marwa; Abouzid, Khaled A M; Serya, Rabah |
| 37 | 1-Jul-2025 | Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds | Ashraf, Rosaline; Adel, Mai; Ibrahim, Esraa; Haffez, Hesham; Soror, Sameh; Abouzid, Khaled A M; Serya, Rabah |
| 38 | Sep-2025 | Discovery of Furopyrimidine-Pyrazole Hybrid Compounds Targeting p53-MDM2 Interaction as Anticancer Agents | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Dege, Necmi; Şahin, Onur; Sharaky, Marwa; Zhang, Xiaoliang; Su, Ruixin; Kong, Dexin; Abouzid, Khaled A M; Serya, Rabah |
| 39 | 1-Dec-2025 | Tackling microbial resistance with 4H-chromen-4-one derivatives as a novel class of penicillin binding protein 2a inhibitors | Shalaby, Menna-Allah W; Abutaleb, Nader S; Elgammal, Yehia; Liang, Hsin-Wen; Abdallah, Inas A; Fishovitz, Jennifer; Seleem, Mohamed N; Abouzid, Khaled A M; Serya, Rabah ; Dokla, Eman |
| 40 | 2026 | Design, synthesis, in silico, and biological evaluation of novel pyrazolopyrimidinone-based estrogen receptor inhibitors | Hesham, Sara A; Ziko, Laila; Serya, Rabah ; Farag, Nahla A; Mowafy, Samar; Shahin, Mai I; Abouzid, Khaled |
Loading...